Bifidobacterium longum is a Gram-positive, catalase-negative, rod-shaped bacterium present in the human gastrointestinal tract and one of the 32 species that belong to the genus Bifidobacterium. It is a microaerotolerant anaerobe and considered to be one of the earliest colonizers of the gastrointestinal tract of infants. When grown on general anaerobic medium, B. longum forms white, glossy colonies with a convex shape. While B. longum is not significantly present in the adult gastrointestinal tract, it is considered part of the gut microbiota and its production of lactic acid is believed to prevent growth of pathogenic organisms. B. longum is non-pathogenic and is often added to food products. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenoma (Phase 2)
Adenomatous Polyposis Coli (Phase 2)
Anxiety Disorders (Phase 4)
Ascites (Phase 2)
Asthma (Phase 2)
Brain Diseases (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Celiac Disease (Phase 4)
Cognitive Dysfunction (Phase 4)
Colic (Phase 4)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 3)
Crohn Disease (Phase 4)
Deglutition Disorders (Phase 1)
Depression (Phase 3)
Depressive Disorder (Phase 3)
Depressive Disorder, Major (Phase 3)
Diarrhea (Phase 3)
Digestive System Diseases (Phase 2)
Diverticulitis (Phase 2)
Dyspepsia (Phase 2)
Enterocolitis (Phase 2)
Esophageal and Gastric Varices (Phase 3)
Fatty Liver (Phase 3)
Fibrosis (Phase 4)
Gastrointestinal Diseases (Phase 2)
Hepatic Encephalopathy (Phase 4)
Hirschsprung Disease (Phase 2)
Hyperbilirubinemia (Phase 3)
Hyperbilirubinemia, Neonatal (Phase 3)
Hyperkinesis (Phase 4)
Hypersensitivity (Phase 4)
Hypothyroidism (Phase 1)
Infections (Phase 3)
Inflammatory Bowel Diseases (Phase 3)
Irritable Bowel Syndrome (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Klebsiella Infections (Phase 2)
Liver Cirrhosis (Phase 4)
Liver Diseases (Phase 3)
Lung Neoplasms (Phase 2)
Metabolic Syndrome (Phase 3)
Nasopharyngeal Neoplasms (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 3)
Osteoporosis (Phase 2)
Osteoporosis, Postmenopausal (Phase 2)
Peritonitis (Phase 3)
Pneumonia (Phase 3)
Postoperative Complications (Phase 4)
Recurrence (Phase 3)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 2)
Signs and Symptoms (Phase 2)
Signs and Symptoms, Digestive (Phase 2)
Stress, Psychological (Phase 3)
Syndrome (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue